Compile Data Set for Download or QSAR
Found 130 with Last Name = 'olsson' and Initial = 't'
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50262998(CHEMBL477548 | mesyl-2-(3-(2-amino-2-oxoacetyl)-1-...)copy SMILEScopy InChI
Affinity DataIC50: 7nMAssay Description:Binding affinity to sPLA2X (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2668FS8PubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008271(CHEMBL3235132)copy SMILEScopy InChI
Affinity DataIC50: 8nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
TargetPhospholipase A2, membrane associated(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50055366((3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-...)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:Inhibition of recombinant human sPLA2-2A expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetProthrombin(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50422375(CHEMBL116616)copy SMILEScopy InChI
Affinity DataIC50: 25nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D21ZWNPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366784(CHEMBL4171084)copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50055366((3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-...)copy SMILEScopy InChI
Affinity DataIC50: 41nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008272(CHEMBL3235133)copy SMILEScopy InChI
Affinity DataIC50: 41nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008279(CHEMBL3235140)copy SMILEScopy InChI
Affinity DataIC50: 41nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366811(CHEMBL4176544)copy SMILEScopy InChI
Affinity DataIC50: 43nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50031106(CHEMBL3337975)copy SMILEScopy InChI
Affinity DataIC50: 51nMAssay Description:Inhibition of human sPLA2X using 1,2-bis(heptanoylthio) glycerophosphocholine substrate incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2668FS8PubMed
TargetProthrombin(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50422376(CHEMBL116149)copy SMILEScopy InChI
Affinity DataIC50: 56nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D21ZWNPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008278(CHEMBL3235139)copy SMILEScopy InChI
Affinity DataIC50: 66nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366983(CHEMBL4160483)copy SMILEScopy InChI
Affinity DataIC50: 68nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008271(CHEMBL3235132)copy SMILEScopy InChI
Affinity DataIC50: 76nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008273(CHEMBL3235134)copy SMILEScopy InChI
Affinity DataIC50: 80nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008269(CHEMBL3235130)copy SMILEScopy InChI
Affinity DataIC50: 87nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366807(CHEMBL4172222)copy SMILEScopy InChI
Affinity DataIC50: 90nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366839(CHEMBL4175583)copy SMILEScopy InChI
Affinity DataIC50: 93nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetGroup 10 secretory phospholipase A2(Mus musculus)
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366784(CHEMBL4171084)copy SMILEScopy InChI
Affinity DataIC50: 96nMAssay Description:Inhibition of mouse sPLA2-10 using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate pretreated for 20 mins followed by substrate additio...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008272(CHEMBL3235133)copy SMILEScopy InChI
Affinity DataIC50: 100nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008274(CHEMBL3235135)copy SMILEScopy InChI
Affinity DataIC50: 106nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50055366((3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-...)copy SMILEScopy InChI
Affinity DataIC50: 107nMAssay Description:Inhibition of human sPLA2X using 1,2-bis(heptanoylthio) glycerophosphocholine substrate incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2668FS8PubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366840(CHEMBL4174522)copy SMILEScopy InChI
Affinity DataIC50: 110nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008273(CHEMBL3235134)copy SMILEScopy InChI
Affinity DataIC50: 117nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008275(CHEMBL3235136)copy SMILEScopy InChI
Affinity DataIC50: 124nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetPhospholipase A2 group V(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50055366((3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-...)copy SMILEScopy InChI
Affinity DataIC50: 124nMAssay Description:Inhibition of recombinant human sPLA2-5 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate p...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetProthrombin(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50422368(CHEMBL117266)copy SMILEScopy InChI
Affinity DataIC50: 135nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D21ZWNPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50055366((3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-...)copy SMILEScopy InChI
Affinity DataIC50: 150nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using HDL as substrate pretreated for 20 mins followed by substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366905(CHEMBL4173359)copy SMILEScopy InChI
Affinity DataIC50: 160nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366889(CHEMBL4175643)copy SMILEScopy InChI
Affinity DataIC50: 170nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50031105(CHEMBL3337976)copy SMILEScopy InChI
Affinity DataIC50: 174nMAssay Description:Inhibition of human sPLA2X using 1,2-bis(heptanoylthio) glycerophosphocholine substrate incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2668FS8PubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366876(CHEMBL4171797)copy SMILEScopy InChI
Affinity DataIC50: 230nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetPantothenate synthetase(Mycobacterium tuberculosis (strain ATCC 25618 / H3...)
Cambridge Crystallographic Data Centre

Curated by ChEMBL
LigandPNGBDBM50180855(CHEMBL3818314)copy SMILEScopy InChI
Affinity DataIC50: 250nMAssay Description:Inhibition of Mycobacterium tuberculosis pantothenate synthetase expressed in Escherichia coliMore data for this Ligand-Target Pair
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366968(CHEMBL4161605)copy SMILEScopy InChI
Affinity DataIC50: 260nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366784(CHEMBL4171084)copy SMILEScopy InChI
Affinity DataIC50: 270nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using HDL as substrate pretreated for 20 mins followed by substrate ...More data for this Ligand-Target Pair
TargetProthrombin(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50422377(CHEMBL116971)copy SMILEScopy InChI
Affinity DataIC50: 288nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D21ZWNPubMed
TargetPhospholipase A2, membrane associated(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366784(CHEMBL4171084)copy SMILEScopy InChI
Affinity DataIC50: 310nMAssay Description:Inhibition of recombinant human sPLA2-2A expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50031107(CHEMBL3337972)copy SMILEScopy InChI
Affinity DataIC50: 316nMAssay Description:Inhibition of human sPLA2X using 1,2-bis(heptanoylthio) glycerophosphocholine substrate incubated for 30 minsMore data for this Ligand-Target Pair
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50031104(CHEMBL3337977)copy SMILEScopy InChI
Affinity DataIC50: 347nMAssay Description:Inhibition of human sPLA2X using 1,2-bis(heptanoylthio) glycerophosphocholine substrate incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2668FS8PubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366983(CHEMBL4160483)copy SMILEScopy InChI
Affinity DataIC50: 370nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using HDL as substrate pretreated for 20 mins followed by substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50031103(CHEMBL3337978)copy SMILEScopy InChI
Affinity DataIC50: 398nMAssay Description:Inhibition of human sPLA2X using 1,2-bis(heptanoylthio) glycerophosphocholine substrate incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2668FS8PubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008269(CHEMBL3235130)copy SMILEScopy InChI
Affinity DataIC50: 400nMAssay Description:Inhibition of TAF1a in human plasma assessed as clot lysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50226610((2S)-5-AMINO-2-[(1-PROPYL-1H-IMIDAZOL-4-YL)METHYL]...)copy SMILEScopy InChI
Affinity DataIC50: 450nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366811(CHEMBL4176544)copy SMILEScopy InChI
Affinity DataIC50: 480nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using HDL as substrate pretreated for 20 mins followed by substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetProthrombin(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50422369(CHEMBL114124)copy SMILEScopy InChI
Affinity DataIC50: 575nMAssay Description:Inhibitory activity against thrombinMore data for this Ligand-Target Pair
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2D21ZWNPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008276(CHEMBL3235137)copy SMILEScopy InChI
Affinity DataIC50: 585nMAssay Description:Inhibition of human TAF1aMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetCarboxypeptidase B2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50008270(CHEMBL3235131)copy SMILEScopy InChI
Affinity DataIC50: 620nMAssay Description:Inhibition of human TAF1a using hippuryl-L-arginine/hippuryl-L-lysine as substrate by liquid chromatographic analysisMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DZ09TGPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366970(CHEMBL4160502)copy SMILEScopy InChI
Affinity DataIC50: 620nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine as substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50031102(CHEMBL3337979)copy SMILEScopy InChI
Affinity DataIC50: 631nMAssay Description:Inhibition of human sPLA2X using 1,2-bis(heptanoylthio) glycerophosphocholine substrate incubated for 30 minsMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2668FS8PubMed
TargetGroup 10 secretory phospholipase A2(Homo sapiens (Human))
AstraZeneca

Curated by ChEMBL
LigandPNGBDBM50366839(CHEMBL4175583)copy SMILEScopy InChI
Affinity DataIC50: 740nMAssay Description:Inhibition of recombinant human sPLA2-10 expressed in Escherichia coli BL21(DE3) using HDL as substrate pretreated for 20 mins followed by substrate ...More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2Z60RMJPubMed
Displayed 1 to 50 (of 130 total ) | Next | Last >>
Jump to: